Back

Viking Therapeutics shares plunge 5.20% as VKTX slips below key trend levels

Verifying
  • Viking Therapeutics shares fell as broader risk aversion pressured Tuesday trading.
  • VKTX dropped 5.20% to $29.90 at publication, according to Benzinga Pro.
  • Viking presented obesity-pipeline updates Monday at the Morgan Stanley Global Healthcare Conference.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.